Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Environ Monit Assess ; 187(1): 4127, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25446717

ABSTRACT

Anthropogenic release of pollutants into the environment is especially harmful to growing fetuses and young children. These populations are at an increased risk of damage because exposure to pollutants during critical periods of development can cause many impairments. Children's exposure to mixtures of metals could be responsible for the rising numbers of neurological disorders surfacing in Iraqi children. Titanium (Ti) and magnesium (Mg) are heavily used in war industries. Exposure to Ti and Mg has been linked to the dust in occupation soldiers' lungs. Hair samples of children in Hawija, Iraq (n = 13) contained significantly higher levels of Ti compared to Iranian children (n = 13) living near the Iraqi border (2080 ± 940 vs 707 ± 421 µg/kg, p < 0.0001). Magnesium was 1.7 times higher in Hawija children compared to Iranian children (115,763 ± 118,155 vs 67,650 ± 46,729 µg/kg). In samples from Hawija, Ti was 1.3 times higher in children with neurodevelopmental disorders (2198 ± 1108 vs 1942 ± 779 µg/kg), and Mg was 1.9 times higher in children without neurodevelopmental disorders (155,618 ± 140,791 vs 81,602 ± 91,940 µg/kg). Lead, arsenic, and cadmium in Hawija children with neurodevelopmental disorders (n = 6) were 2.5, 2.2, and 1.37 times higher compared to non-disabled children (n = 7). To get a clear understanding of the current status of neurodevelopmental disorders in Iraqi children and to determine the magnitude of this suspected global health issue, registries should be set up to compile and aggregate data from hospitals, clinics, and health centers across the country. Functional registries can develop collaborations with researchers toward finding causes of these disorders in Iraqi children and toward preventing them.


Subject(s)
Environmental Exposure/statistics & numerical data , Environmental Monitoring , Environmental Pollutants/metabolism , Nervous System Diseases/epidemiology , Titanium/metabolism , Child , Humans , Iraq/epidemiology , Nervous System Diseases/metabolism
2.
Eur J Pediatr ; 172(1): 91-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23052617

ABSTRACT

UNLABELLED: Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by intermittent episodes of fever with serositis, arthritis, or eriseplemya. Plasminogen activator inhibitor 1 (PAI-1) is a key element in the inhibition of fibrinolysis by inactivating tissue-type and urokinase-type plasminogen activators. We evaluated the association of PAI-1 -675 4G/5G polymorphism with the severity of FMF disease. For this purpose, 89 FMF patients with M694V homozygous mutation and 95 healthy controls from Iranian Azeri Turks were selected. Detection of this polymorphism was performed by polymerase chain reaction using allele-specific primers. No significant association was found between patients and control group. However, these data showed that FMF patients with M694V homozygous mutation carrying 4G/4G genotype have a reduced risk for development of pleuritis (odds ratios (OR) 0.36; 95 % confidence intervals (CI) 0.5-0.85; P value = 0.007) compared with 5G/5G homozygotes who have increased risk for development of amyloidosis (OR = 2.46; 95 %CI = 1.29-4.72; P value = 0.001), pleuritis (OR = 2.55; 95 %CI = 1.31-4.99; P value = 0.001), and fever (OR = 4.68; 95 %CI = 2.04-10.96; P value = 0.000). Furthermore, the allelic frequency of the 4G among the patients with pleuritis was significantly low (OR = 0.5, 95 % CI = 0.27-0.92, P value = 0.008). CONCLUSION: Our data suggest a protective role for the 4G allele against pleuritis in FMF patients with M694V homozygous mutation in this cohort. More evaluation of this polymorphism may be important and require further studies.


Subject(s)
Amyloidosis/genetics , Familial Mediterranean Fever/genetics , Plasminogen Activator Inhibitor 1/genetics , Amyloidosis/complications , Azerbaijan , Case-Control Studies , Child , Familial Mediterranean Fever/complications , Female , Genetic Predisposition to Disease , Homozygote , Humans , Iran , Male , Mutation , Polymerase Chain Reaction , Polymorphism, Genetic , Risk Factors , Turkey
3.
Bull Environ Contam Toxicol ; 89(5): 937-44, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22983726

ABSTRACT

Between October 1994 and October 1995, the number of birth defects per 1,000 live births in Al Basrah Maternity Hospital was 1.37. In 2003, the number of birth defects in Al Basrah Maternity Hospital was 23 per 1,000 live births. Within less than a decade, the occurrence of congenital birth defects increased by an astonishing 17-fold in the same hospital. A yearly account of the occurrence and types of birth defects, between 2003 and 2011, in Al Basrah Maternity Hospital, was reported. Metal levels in hair, toenail, and tooth samples of residents of Al Basrah were also provided. The enamel portion of the deciduous tooth from a child with birth defects from Al Basrah (4.19 µg/g) had nearly three times higher lead than the whole teeth of children living in unimpacted areas. Lead was 1.4 times higher in the tooth enamel of parents of children with birth defects (2,497 ± 1,400 µg/g, mean ± SD) compared to parents of normal children (1,826 ± 1,819 µg/g). Our data suggested that birth defects in the Iraqi cities of Al Basrah (in the south of Iraq) and Fallujah (in central Iraq) are mainly folate-dependent. This knowledge offers possible treatment options and remediation plans for at-risk Iraqi populations.


Subject(s)
Congenital Abnormalities/epidemiology , Environmental Exposure/analysis , Environmental Pollutants/analysis , Metals/analysis , Congenital Abnormalities/metabolism , Environmental Exposure/statistics & numerical data , Environmental Pollutants/metabolism , Environmental Pollution/statistics & numerical data , Hair/metabolism , Humans , Infant, Newborn , Iraq/epidemiology , Lead/metabolism , Mercury/metabolism , Metals/metabolism , Nails/metabolism , Tooth/metabolism , Uranium/metabolism
4.
Iran J Cancer Prev ; 5(1): 21-6, 2012.
Article in English | MEDLINE | ID: mdl-25780535

ABSTRACT

BACKGROUND: Epidemiologic and molecular evidences have established a strong link between high risk types of Human Papilloma Virus and a subgroup of Head and Neck Squamous Cell Carcinomas (HNSCC). We evaluated the frequency of HPV positivity in HNSCC and its relationship to demographic and some risk factor variables in an open case- control study. METHODS: Fourteen recently diagnosed patients with squamous cell cancer of oropharynx, hypopharynx and larynx aged 18-50 years were examined from 2008-2010 in Tabriz, Iran. HPV DNA was extracted from paraffin-embedded blocks of each patient's sample for PCR evaluation. Saliva samples of 94 control cancer-free subjects were collected for DNA analysis. Multivariable logistic regression method was used to calculate odds ratio for case-control comparisons. RESULTS: High risk HPV was detected in 6(42.8%) patients, and 6(5.3%) control subjects which was statistically significant (p<0.0001). HPV-18 was the most frequent type both in the cases and controls. HPV-16 DNA was detected in two patients of the case group, but it was not detected in any of the controls. The relation between demographic and risk factor variables was not statistically significant. CONCLUSION: HPV infection has a significant impact on HNSCC. Despite HPV-16 stronger impact, HPV-18 is more likely to cause malignant degeneration in such cancers amongst some communities. It is vital to introduce and conduct immunization schedules in health care systems to protect communities to some extent.

5.
Scand J Rheumatol ; 40(5): 383-6, 2011.
Article in English | MEDLINE | ID: mdl-21623663

ABSTRACT

OBJECTIVE: Behçet's disease (BD) is an inflammatory disorder of unknown cause with higher prevalence along the ancient Silk Road. BD shares epidemiological and clinical features with familial Mediterranean fever (FMF). Moreover, association of BD and certain MEFV gene mutations has been described in recent decades. We studied the role of MEFV mutations in Iranian Azeri Turkish patients with BD. METHODS: Fifty-three BD patients who met the International Study Group criteria for BD were analysed for five common MEFV mutations (M694V, V726A, M680I, M694I, and E148Q) using amplification refractory mutation system and polymerase chain reaction (PCR) restriction-digestion testing methods. A cohort of 200 healthy Azeri Turkish individuals who had been previously genotyped regarding the five common MEFV mutations served as the control group. RESULTS: Eighteen patients were found to carry a single MEFV mutation and one additional patient was compound heterozygote. There was a statistically significant difference between the patient group and ethnically matched healthy individuals regarding M694V and M680I mutations (p = 0.01 and p = 0.04, respectively). Both BD groups (carriers and non-carriers of MEFV mutations) were similar in their clinical symptoms. CONCLUSION: Definite MEFV mutations seem to be a susceptibility factor for BD in our cohort of Iranian Azeri Turkish patients.


Subject(s)
Behcet Syndrome/genetics , Cytoskeletal Proteins/genetics , Adolescent , Adult , Behcet Syndrome/epidemiology , Ethnicity/genetics , Ethnicity/statistics & numerical data , Familial Mediterranean Fever/epidemiology , Familial Mediterranean Fever/genetics , Female , Gene Frequency , Genetic Predisposition to Disease/epidemiology , Heterozygote , Humans , Iran , Male , Middle Aged , Mutation , Prevalence , Pyrin , Turkey/ethnology , Young Adult
6.
Indian J Cancer ; 48(4): 406-9, 2011.
Article in English | MEDLINE | ID: mdl-22293252

ABSTRACT

Breast cancer represents 27% of the cancers and 19% of the cancer deaths in female population. The aim of this study was to document the age pattern of the incidence of breast cancer in Iranian female population in the northwest region of the country. The study subjects were 1764 patients with breast cancer diagnosed/registered in the six university clinics between 1988 and 2008 in the northwest of Iran. The highest occurrence rates were observed for the birth year cohorts 1940-1949 (for 59-69 years old), 1950-1959 (for 49-58 years old), and 1960-1969 (for 39-48 years old). Among these three cohorts, the highest rate was observed in 1950-1959 birth year cohort (284.38 per 100,000 female populations, 95% CI: 260-310). This rate was significantly higher compared with the similar rates of other birth cohorts. There was no statistically significant difference between various years in terms of the average age at the diagnosis of breast cancer in our study setting. Despite the previous research reports, we found no significant difference between the mean ages at diagnosis of breast cancer from 1988 to 2008 in Iranian female population.


Subject(s)
Breast Neoplasms/epidemiology , Carcinoma/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Breast Neoplasms/physiopathology , Carcinoma/pathology , Carcinoma/physiopathology , Child , Child, Preschool , Female , Humans , Incidence , Infant , Iran/epidemiology , Middle Aged , Prevalence
7.
Hematology ; 13(4): 253-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18796253

ABSTRACT

BACKGROUND: Thalassemia trait (THA) is an important differential diagnosis of iron deficiency anemia (IDA). The red cell distribution width (RDW) is usually elevated in IDA, but often is normal in THA. OBJECTIVE: This study was conducted to determine the usefulness of red cell flags in differentiating iron deficiency anemia and thalassemia trait. METHODS: Peripheral blood samples from 50 patients suffering iron deficiency anemia and 64 patients suffering thalassemia trait were used to determine red cell flags (RCF) along with complete blood count, red cell distribution width, serum iron and total iron binding capacity, ferritin and hemoglobin electrophoresis. According to the data collected in this study, the first digit of red cell flags (RCF1)=0 was almost three times higher in thalassemic patients compared to those of iron deficiency anemia. Another reverse significant difference was observed in RCF1=2 (6.3% versus 42% for thalassemia and iron deficiency anemia respectively). CONCLUSION: We conclude that RCF findings are sensitive and specific enough to be used as an approach in differentiating iron deficiency anemia from beta-thalassemia trait.


Subject(s)
Anemia, Iron-Deficiency/blood , Anemia, Iron-Deficiency/diagnosis , Erythrocytes/pathology , beta-Thalassemia/blood , beta-Thalassemia/diagnosis , Adult , Diagnosis, Differential , Erythrocyte Count , Erythrocyte Indices , Female , Humans , Male , Sensitivity and Specificity
8.
Int J STD AIDS ; 18(6): 407-9, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17609032

ABSTRACT

The aim of this study was to assess the impact of an educational course on knowledge and attitude of students regarding HIV/AIDS prevention in Tabriz, Iran. The study was conducted by self-assessment technique among university students before and after an educational training programme. The findings showed that the knowledge of students increased significantly (P<0.05). The attitude to the problem also improved positively in the subjects (P<0.05). It is concluded that short-term training courses and continuous educational programmes (i.e. peer education, etc.) should be provided to young students through the course materials in the universities and schools promoting the awareness and attitude to this ever-increasing health problem.


Subject(s)
Acquired Immunodeficiency Syndrome/prevention & control , HIV Infections/prevention & control , HIV , Health Education , Health Knowledge, Attitudes, Practice , Acquired Immunodeficiency Syndrome/psychology , Adolescent , Adult , Female , HIV Infections/psychology , Humans , Iran , Male , Self-Assessment , Surveys and Questionnaires
9.
Child Care Health Dev ; 33(3): 257-61, 2007 May.
Article in English | MEDLINE | ID: mdl-17439438

ABSTRACT

BACKGROUND: At least one congenital anomaly is present in between 1% and 6% of all infants throughout the world. The aim of this study was to document some epidemiological features of congenital anomalies in the North-West of Iran. METHODS: The study cases (n = 1574) comprised all births registered/notified to three university-hospitals of Tabriz University of Medical Sciences, Iran, from 2000 to 2004. RESULTS: Total prevalence of congenital anomalies was 165.5 per 10 000 births [95% confidence interval (CI): 157-174]. Genito-urinary tract and kidney defects, anomalies of nervous system and limb anomalies accounted proportionally for more than 65% of anomalies in the region. The total prevalence of congenital anomalies in the study area increased from 104.6 per 10 000 births in 2000 (95% CI: 90-119) to 170.1 per 10 000 births in 2004 (95% CI: 152-189). CONCLUSIONS: It is concluded that the data from this cross-sectional study of congenital anomalies in the North-West of Iran may be used as the baseline information to establish a population-based registry of birth defects in the area for health care and research purposes.


Subject(s)
Congenital Abnormalities/epidemiology , Cross-Sectional Studies , Female , Humans , Infant, Newborn , Iran/epidemiology , Limb Deformities, Congenital/epidemiology , Male , Nervous System Malformations/epidemiology , Prevalence , Urogenital Abnormalities/epidemiology
10.
Dis Esophagus ; 19(4): 238-40, 2006.
Article in English | MEDLINE | ID: mdl-16866853

ABSTRACT

Esophageal squamous cell carcinoma is the 6th most commonly occurring cancer worldwide. A relationship between HLA A1 and B40 and esophageal cancer was described in patients examined in China. The aim of this study was to investigate the relation of HLA class 1 and esophageal carcinoma in the northwestern region of Iran. Using specific monoclonal antibodies, different human leukocyte antigens (HLA) were quantified in 100 patients suffering esophageal carcinoma in Tabriz, a major city located in the Northwestern region of Iran. These data were compared to those of 100 healthy matched individuals as a control group from the same region. HLA B14 and A24 were increased and showed statistically significant correlation in squamous cell carcinoma. These findings may also indicate the association between genetic factors and esophageal carcinoma. Further studies are suggested for detecting correlation of HLA and esophageal carcinoma in other regions.


Subject(s)
Esophageal Neoplasms/immunology , HLA Antigens/blood , Adenocarcinoma/genetics , Adenocarcinoma/immunology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/immunology , Esophageal Neoplasms/genetics , Female , HLA-A Antigens/blood , HLA-A1 Antigen/blood , HLA-A24 Antigen , HLA-B Antigens/blood , HLA-B14 Antigen , HLA-B40 Antigen , Humans , Iran , Male , Middle Aged
12.
Arch Dis Child ; 88(5): 391-4, 2003 May.
Article in English | MEDLINE | ID: mdl-12716706

ABSTRACT

AIM: To describe the survival to age 5 years of children born with congenital anomalies. METHODS: Between 1980 and 1997, 6153 live born cases of congenital anomaly were diagnosed and registered by the population based Glasgow Register of Congenital Anomalies. They were retrospectively followed to assess their survival status from birth up to the age of 5 years. RESULTS: The proportions of all live born infants with congenital anomalies surviving to the end of the first week, and first and fifth year were 94%, 89%, and 88%, respectively. Survival to age 5, the end point of follow up, was significantly poorer for infants with chromosomal anomalies (48%) compared to neural tube defects (72%), respiratory system anomalies (74%), congenital heart disease (75%), nervous system anomalies (77%), and Down's syndrome (84%). CONCLUSION: Although almost 90% of all live born infants with congenital anomalies survive to 5 years, there are notable variations in survival between anomaly types. Our findings should be useful for both clinicians and geneticists to assess the prognosis of congenital anomalies. This information is also important for affected families and for the planning of health care needs for this high risk population.


Subject(s)
Congenital Abnormalities/mortality , Child, Preschool , Humans , Infant , Infant, Newborn , Retrospective Studies , Scotland/epidemiology , Survival Rate/trends , Time Factors
13.
Arch Dis Child ; 86(4): 257-63, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11919098

ABSTRACT

AIM: To describe the epidemiology of congenital anomalies in Glasgow with special reference to secular trends. METHODS: The prevalence of congenital anomalies was determined retrospectively in 233 777 births using the Glasgow Register of Congenital Anomalies for the period 1980-97. RESULTS: The total prevalence of congenital anomalies was 324 per 10 000 births, declining by just over a third from 382 per 10 000 births in 1980 to 238 per 10 000 births in 1997. The categories of defects with the highest prevalence were congenital heart disease (50 per 10 000 births), anomalies of limbs (49 per 10 000 births), and digestive system anomalies (47 per 10 000 births). Prevalence in most categories of anomaly declined, including those of the ear (-88%), congenital heart disease (-69%), anomalies of integument (-67%), nervous system anomalies (-61%), anomalies of limb (-54%), and urogenital (including renal) anomalies (-31%). By contrast, there was a significant upward trend for chromosomal anomalies (+50%). CONCLUSIONS: Despite the decline in the prevalence of many types of congenital anomaly, around 2.5% of all births in Glasgow were still associated with these disorders in 1997. In attempting to explain the prevalence and secular trend of congenital anomalies in Glasgow, underlying contributing factors require to be considered. These include changes in case ascertainment, antenatal screening, and diagnostic methods.


Subject(s)
Congenital Abnormalities/epidemiology , Humans , Infant, Newborn , Prevalence , Regression Analysis , Scotland/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...